A leap towards enforcing medicines prescribing by generic names in low- and middle-income countries (LMICs): pitfalls, limitations, and recommendations for local drug regulatory agencies

The Drug Regulatory Authority of Pakistan (DRAP) in response to the public outcry on increasing medicines prices in the country issued notifications to direct healthcare professionals to prescribe medicines with their generic names. Like DRAP, many regulators in the low- and middle-income countries...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Hamid A. Merchant, Zaheer-Ud-Din Babar, Izhar M. Hussain
Format:	Artigo
Jezik:	Inglês
Izdano:	Taylor & Francis Group 2022-12-01
Serija:	Journal of Pharmaceutical Policy and Practice
Teme:	drap prescribing low-cost generics access to medications bioequivalence biosimilars biowaivers low- and middle-income countries (lmics)
Online dostop:	http://dx.doi.org/10.1186/s40545-022-00501-4
Oznake:	Označite Brez oznak, prvi označite!